Brain & Behavior Research Foundation Hosts 2026 International Symposium on Mental Health Research
Meeting Announcement
Updates every hour. Last Updated: 30-Oct-2026 10:16 ET (30-Oct-2026 14:16 GMT/UTC)
A person’s capacity to regulate their emotions apparently cannot be determined by the activity of the prefrontal brain regions typically associated with this process. This is shown by an international fMRI analysis conducted by Dr. Maurizio Sicorello of the Central Institute for Mental Health (CIMH) and Prof. Dr. Carmen Morawetz of the University of Innsbruck, using data from 2,175 people across 40 studies. The study, published in Nature, challenges widespread assumptions about the neural basis of emotion regulation and highlights where task-based imaging reaches its limits when it comes to differences between individuals.
Australian researchers map, in unprecedented detail, the immune cells through which genetic differences between people influence disease. The researchers analysed the gene sequence and activity of more than 5 million individual immune cells from nearly 2,000 people, the largest dataset of its kind in the world. The findings open a path to precision medicine for diseases ranging from autoimmune conditions like multiple sclerosis to neurological conditions such as Alzheimer’s and cancers including breast and prostate.
A family of mutations seen in about 20% of human cancers drives malignancy by changing the accessibility of genes to a particular regulatory protein, according to a study by Weill Cornell Medicine investigators. The findings suggest new therapeutic strategies for a variety of cancer types.
A study in Eye Discovery comparing 29 children with Marcus Gunn jaw-winking syndrome and 57 children with simple congenital blepharoptosis suggests that children with MGJWS may face greater risks of impaired visual development and reduced hyperopic reserve, underscoring the need for individualized assessment of surgical timing.
A new study led by Boston University researchers estimates that nearly 75% of all NFL players who died between 2008 and 2023 had chronic traumatic encephalopathy (CTE) neuropathology. CTE is a neurodegenerative disease that has been diagnosed in individuals with substantial exposure to repetitive head impacts. It can only be definitively diagnosed after death.
Exoskeletons, advanced prostheses and wearables have entered the workplace and are here to stay, but their adoption presents significant challenges